These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4698962)

  • 21. In vitro and in vivo recovery of cryoprecipitated factor 8.
    Verstraete M; Lust A; Vermylen J
    Bibl Haematol; 1970; 34():9-17. PubMed ID: 5436359
    [No Abstract]   [Full Text] [Related]  

  • 22. Cryoprecipitate in the management of haemophilia in Kenya.
    Taylor JR; Ahluwalia NS; Morrison CJ; Kaviti JN; Cardwell CL
    East Afr Med J; 1969 Feb; 46(2):121-8. PubMed ID: 5798053
    [No Abstract]   [Full Text] [Related]  

  • 23. A method for the production of AHG rich cryoprecipitates & their use in the management of bleeding episodes in haemophilia.
    Kwa SB; Chen YF
    Singapore Med J; 1968 Mar; 9(1):12-6. PubMed ID: 5659889
    [No Abstract]   [Full Text] [Related]  

  • 24. Fractions rich in factor VIII.
    Biggs R
    Bibl Haematol; 1968; 29():1122-6. PubMed ID: 5750137
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of congenital deficiencies of factor VIII and factor IX.
    Rizza CR; Biggs R
    Thromb Diath Haemorrh Suppl; 1968; 35():73-84. PubMed ID: 5317365
    [No Abstract]   [Full Text] [Related]  

  • 26. Home treatment of haemophilia and Christmas disease: five years' experience.
    Rizza CR; Spooner RJ
    Br J Haematol; 1977 Sep; 37(1):53-66. PubMed ID: 588479
    [No Abstract]   [Full Text] [Related]  

  • 27. Haemophilia.
    Biggs R
    Proc R Soc Med; 1969 Sep; 62(9):913-4. PubMed ID: 4241884
    [No Abstract]   [Full Text] [Related]  

  • 28. Utilization of the residual plasma following preparation of factor VIII cryoprecipitate.
    Oberman HA; Penner JA
    JAMA; 1968 Sep; 205(12):819-21. PubMed ID: 5695503
    [No Abstract]   [Full Text] [Related]  

  • 29. Cryoprecipitate: a safe factor VIII replacement.
    Kletzel M; Charlton R; Becton D; Berry DH
    Lancet; 1987 May; 1(8541):1093-4. PubMed ID: 2883430
    [No Abstract]   [Full Text] [Related]  

  • 30. Freeze dried cryoprecipitate: a clinical evaluation.
    Hambley H; Davidson JF; Walker ID; Small M; Prentice CR
    J Clin Pathol; 1983 May; 36(5):574-6. PubMed ID: 6404949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The appearance of anti-thrombocyte and anti-leukocyte antibodies in hemophilia A patients after cryoprecipitate transfusions].
    Uteg KH; Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(5):771-6. PubMed ID: 64419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate].
    Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R
    Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915
    [No Abstract]   [Full Text] [Related]  

  • 33. Prepooled cryoprecipitate for treatment of hemophilia A.
    Menitove JE; Spero JA; Richards WA; Lewis JH; Montgomery RR; Gill JC; Hasiba U; Wheeler DV; Sherwin JA; Russell-Vaskov S; Marlar RA; Maxwell NG; Aster RH
    Transfusion; 1983; 23(3):265-7. PubMed ID: 6407160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Safe and cost-conscious supply of factor-VIII-deficient Swiss hemophiliacs with AHF preparations].
    Stampfli K
    Ther Umsch; 1977 Oct; 34(10):717-24. PubMed ID: 918896
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma fractions for the treatment of hemophilia. 1. On the preparation and use of fraction I-O.
    Blombäck M; Blombäck B
    Thromb Diath Haemorrh Suppl; 1969; 35():21-5. PubMed ID: 5317539
    [No Abstract]   [Full Text] [Related]  

  • 36. [Unsolved therapeutic problems of hemophilia].
    Fedorova ZD; Kotovshchikova MA; Andreeva TA
    Gematol Transfuziol; 1983 Aug; 28(8):55-61. PubMed ID: 6414877
    [No Abstract]   [Full Text] [Related]  

  • 37. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions.
    Schimpf K; Mannucci PM; Kreutz W; Brackmann HH; Auerswald G; Ciavarella N; Mösseler J; DeRosa V; Kraus B; Brueckmann C
    N Engl J Med; 1987 Apr; 316(15):918-22. PubMed ID: 3102963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential prevalence of antibody to AIDS-associated retrovirus in haemophiliacs treated with Factor VIII concentrate versus cryoprecipitate: recovery of infectious virus.
    Koerper MA; Kaminsky LS; Levy JA
    Lancet; 1985 Feb; 1(8423):275. PubMed ID: 2857339
    [No Abstract]   [Full Text] [Related]  

  • 39. Cryoprecipitate.
    Armstrong D
    S Afr Med J; 1975 Jul; 49(31):1245-7. PubMed ID: 1154189
    [No Abstract]   [Full Text] [Related]  

  • 40. A little freedom for the hemophiliac.
    Britten AF
    N Engl J Med; 1970 Nov; 283(19):1051-2. PubMed ID: 5470269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.